Masimo | MASI - Equity Capital And Reserves

Stock Price
134.73
Daily Change
-1.89 -1.38%
Monthly
-1.37%
Yearly
-25.16%
Q1 Forecast
133.10

Masimo reported $810M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
AtriCure USD 476.51M 12.02M Sep/2025
Avanos Medical USD 778M 1.7M Sep/2025
Baxter International USD 7.24B 79M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Boston Scientific USD 22.65B 235M Sep/2025
Dexcom USD 2.73B 153M Sep/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Globus Medical USD 4.4B 103.14M Sep/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Insulet USD 1.38B 78.8M Sep/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
Masimo USD 810M 232.8M Sep/2025
Medtronic USD 47.89B 131M Jun/2025
Owens Minor USD -429.51M 148.5M Sep/2025
ResMed USD 6.32B 199.61M Dec/2025
Steris USD 7.01B 52.1M Sep/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 132.96M 318K Sep/2025
Teleflex USD 3.82B 421M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025